483
DIAGASTDIAGAST – FDA 483, Apr 19, 2024
Record Details
Diagast, a Biologics IVD Manufacturer in Loos, France, was cited for multiple significant quality system deficiencies during an FDA inspection. Observations included failures in Medical Device Reporting (MDR) submission and procedures, inadequate risk analysis for blood grouping reagents, and insufficient control over storage area temperature excursions. The firm also failed to document biological deviation reports and in-process quality control activities.
View Company Profile
ID · 67f5c92e-29c7-41e9-a8ad-751922764c72
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.